LOINC Code 94195-5: CPT2 gene full mutation analysis Sequencing Doc (Bld/Tiss)

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component CPT2 gene full mutation analysis. It is commonly used with the system or sample type Bld/Tiss.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Both
• Method: Sequencing

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• CPT2 gene full mutation analysis in Blood or Tissue by Sequencing
• CPT2 gene full mutation analysis
• Full sequence analysis of the CPT2 gene is performed to confirm a patient's diagnosis of carnitine palmitoyltransferase II deficiency, an autosomal recessive disorder of long-chain fatty-acid oxidation. Testing may also be performed for carrier screening in cases where there is a family history of carnitine palmitoyltransferase II deficiency but disease-causing mutations have not been identified in an affected individual.
• Blood; carnitine palmitoyltransferase 2; carnitine palmitoyltransferase 2 gene; carnitine palmitoyltransferase II gene; CPT1; CPTASE; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; IIAE4; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions